TrialPloS one2020

A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19).

Cheng-Pin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.